New Astaxanthin Ingredient Targets Supplement Capsules

Adults using astaxanthin supplements may see a more oxidation-resistant option, though human evidence is still small.

Updated on Nov. 6, 2026 in Nutrition

Unlabeled red-orange capsules rest on a pale laboratory bench beside a glass flask of crimson-green microalgae culture.
AstaReal launched AstaReal EB15, an encapsulated astaxanthin ingredient for human supplement capsules, aiming to resist oxidation in finished products. AI Illustration. Upload story photo >

AstaReal has launched AstaReal EB15, an encapsulated astaxanthin ingredient designed for human dietary supplements. The ingredient, previously used in animal feed, is built for two-piece, HPMC and gelatin capsules and contains at least 1.5% natural astaxanthin derived from the freshwater microalga Haematococcus pluvialis.

Why it matters

Astaxanthin is a carotenoid that is sensitive to oxygen, so its stability in finished products has been a practical challenge for manufacturers. Encapsulation that protects it from oxidation could make the ingredient more dependable in supplement formats that are exposed to more oxygen.

The human evidence cited is a small study of 20 active women, affiliated with AstaReal, which found greater fat use during moderate exercise after two weeks of 12 mg daily astaxanthin. Stability results come from the company's own testing in two-piece capsules, and the study is preliminary and not independently replicated in the source.

The players

AstaReal AB

A Swedish ingredient company focused on natural astaxanthin, a carotenoid studied for antioxidant and exercise-related applications.

Kuehnle AgroSystems

A Hawaiian algal biotechnology company that produces natural astaxanthin using proprietary dark fermentation technology.

The details

Astaxanthin oxidizes readily when exposed to oxygen, which can reduce its potency in finished products. EB15's encapsulation is designed to shield the astaxanthin from oxidation, which AstaReal says supports stability in two-piece capsules. The natural astaxanthin itself is derived from Haematococcus pluvialis, a freshwater microalga, and the ingredient is produced at a facility approved for food.

Timeline

  1. July: AstaReal-affiliated study on astaxanthin and fat use was published.

  2. July: Kuehnle AgroSystems closed a multi-million-dollar Series B financing.

  3. November 6, 2026: AstaReal launched EB15.

Health Landscape

Microalgal astaxanthin has been established in animal feed, and its move into human supplements reflects growing interest in natural carotenoid ingredients. The development sits within a supplement market where ingredient stability and capsule compatibility are central manufacturing concerns.

If you take or are considering astaxanthin supplements, EB15 is a formulation option that may appear in future capsule products, but the human evidence behind it is limited. It is worth discussing any supplement with your doctor before adding it to your routine.

The takeaway

Encapsulation can protect sensitive ingredients like astaxanthin from oxygen, but manufacturer data is not the same as clinical proof. Look for independent trials before expecting any supplement to deliver a specific benefit.

Further reading

For more on how ingredients like this fit into daily eating, see our Nutrition coverage.

Source note: This article includes information reported by Nutritioninsight.